| Literature DB >> 1154017 |
Abstract
A multicentre clinical trial of clomipramine in the treatment of obsessional and phobic disorders in general practice is described. All phobias showed an improvement in situational anxiety, interference and autonomic side effects. With the exception of two cases of animal phobia there was also improvement in general anxiety and avoidance. Obsessional cases showed an overall improvement in all symptom areas.Entities:
Mesh：
Substances：
Year: 1975 PMID： 1154017 DOI： 10.1177/00369330750200S113
Source DB: PubMed Journal: Scott Med J ISSN： 0036-9330 Impact factor: 0.729